Form 4: Omega Healthcare Investors Director Anand Kapila K Acquires Deferred Stock Units

Director Anand Kapila K acquired 5,756 deferred stock units in Omega Healthcare Investors, Inc., convertible to common stock, as part of an annual grant.

Summary

• Anand Kapila K, a director of Omega Healthcare Investors Inc. (OHI), acquired 5,756 deferred stock units on June 7, 2024.
• These units are part of an annual grant and are convertible to common stock on a one-to-one basis.
• The units are restricted from transfer and sale until Omega's 2025 Annual Meeting of Shareholders.
• Dividends can also be converted into Deferred Stock Units if the participant elects.
• Following the transaction, Anand Kapila K directly owns 33,772 deferred stock units.
• Kapila K. Anand has granted power of attorney to Robert O. Stephenson, Gail D. Makode, Thomas H. Peterson and Meghan C. Lyons to handle SEC filings related to Omega Healthcare Investors, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction (acquisition of deferred stock units) by a company director, which is generally a positive sign but not significantly impactful.

Positives

• The acquisition of deferred stock units by a director signals confidence in the company's future performance.

Future Outlook

The deferred stock units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock.

Stakeholder Impact

• The acquisition of deferred stock units by a director can positively influence shareholder sentiment.

Key Dates